"The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has recommended restricting the use of codeine for cough and cold in children because there is a risk for serious adverse effects, including respiratory"...
Cough and Upper Respiratory Allergy Symptoms
Vituz® Oral Solution is indicated for relief of cough and symptoms associated with upper respiratory allergies or a common cold in adults 18 years of age and older.
Important Limitations of Use
Not indicated for pediatric patients under 18 years of age [see Use In Specific Populations].
DOSAGE AND ADMINISTRATION
Administer Vituz Oral Solution by the oral route only. Measure Vituz Oral Solution with an accurate milliliter measuring device. Do not use a household teaspoon to measure the dose [see WARNINGS AND PRECAUTIONS].
Adults 18 Years of Age and Older
5 mL every 4 to 6 hours as needed, not to exceed 4 doses (20 mL) in 24 hours.
Dosage Forms And Strengths
Vituz is a clear, colorless to light yellow, grape-flavored liquid.
5 mL of Vituz Oral Solution contains: hydrocodone bitartrate, USP, 5 mg and chlorpheniramine maleate, USP, 4 mg [see DESCRIPTION].
Storage And Handling
Vituz Oral Solution is supplied as a clear, colorless to light yellow, grape-flavored solution containing 5 mg hydrocodone bitartrate and 4 mg chlorpheniramine maleate in each 5 mL. It is available in:
White HDPE bottles of one pint (480 mL): NDC 63717-877-16
Store solution at 20° to 25°C (68° to 77°F). [USP Controlled Room Temperature.]
Dispense in a tight, light-resistant container, as defined in the USP, with a child-resistant closure.
Manufactured for: Hawthorn Pharmaceuticals, Inc., Madison, MS 39110 Vituz® Oral Solution is a Registered Trademark of Hawthorn Pharmaceuticals, Inc.
Last reviewed on RxList: 3/1/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Vituz Information
Report Problems to the Food and Drug Administration
Find out what women really need.